Editorial
Editorial commentary on: “Reduced vs full-dose BCG therapy in bladder cancer: A systematic review and meta-analysis”
Comentario editorial sobre «Dosis reducida vs. dosis completa de BCG en el cáncer de vejiga: Revisión sistemática y metaanálisis»
D.M. Carriona,b,c,
, B. Praderec,d,e, F. Soriac,f, F. del Giudicec,g, M. Moschinic,h
Corresponding author
a Department of Urology, Torrejon University Hospital, Universidad Francisco de Vitoria, Madrid, Spain
b Instituto de Cirugía Urológica Avanzada (ICUA), Clínica CEMTRO, Madrid, Spain
c European Association of Urology — Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group
d Department of Urology UROSUD, Croix Du Sud Hospital, Quint-Fonsegrives, France
e Department of Urology, Medical University of Vienna, Vienna, Austria
f Department of Urology, AOU Citta della Salute e della Scienza, Torino School of Medicine, Turin, Italy
g Department of Maternal Infant and Urologic Sciences, Sapienza University of Rome, Policlinico Umberto I Hospital, Rome, Italy
h Department of Urology, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy
